{
  "slug": "tuberculosis-global",
  "question": "What are the odds of dying from tuberculosis?",
  "quick_answer": "TB kills about 1.23 million people a year worldwide — roughly a 1 in 110 lifetime chance of death for the average global adult. Western readers tend to treat it as a historical disease, underestimating a burden that remains among the world's leading infectious killers.\n",
  "category": "health",
  "no_reliable_estimate": false,
  "perceived": {
    "description": "In wealthy countries, tuberculosis is widely treated as a 19th-century disease — the illness of Victorian novels, sanatoriums, and Keats, not of 2026. Most Likelier readers in the US, Western Europe, Japan, or Australia would guess their personal odds of dying from TB at essentially zero, and for them that guess is roughly correct. What the same readers almost universally get wrong is the global picture: TB has been the world’s leading infectious-disease killer for most of the past decade, it regained that title from COVID-19 in 2023, and it kills roughly twice as many people every year as HIV/AIDS. We have not found a cross-national survey that isolates “fear of dying from TB” as a clean question, so the perceived side here is editorial intuition, not polled data.\n",
    "rough_estimate": "Western readers treat it as a historical disease; the global burden is ~1.25 million deaths per year",
    "kind": "intuition"
  },
  "native": {
    "display": "~1.23 million global TB deaths per year (2024)",
    "numerator": 1230000,
    "denominator": 8000000000,
    "unit": "per year",
    "population": "global, all ages (WHO Global TB Report 2025, reference year 2024)"
  },
  "normalized": {
    "lifetime_us_adult": 0.0092,
    "display": "~1 in 110 lifetime (global adult average)",
    "log_value": -2.04,
    "assumptions": "Refreshed 2026-06-14 to the WHO Global Tuberculosis Report 2025 headline figure for reference year 2024: ~1.23 million TB deaths (including ~150,000 among people with HIV), a small decline from the ~1.25 million reported for 2023 in the 2024 report. Divided by a global population of ~8 billion gives an annual per-capita hazard of ~1.54 × 10⁻⁴. Compounded over 60 adult life-years: 1 − (1 − 1.54e-4)^60 ≈ 9.2 × 10⁻³, or roughly 1 in 109 global adult lifetime. The uncertainty band reflects the spread between WHO programmatic estimates (~1.23–1.25M) and GBD 2021 estimates (~1.35M), plus the WHO 95% UI on annual TB deaths. This is a global-average scale marker only — see the regional breakdown below. For residents of the US, Western Europe, Japan, and Australia, the actual figure is roughly five orders of magnitude lower.\n",
    "uncertainty": {
      "low": 0.0075,
      "high": 0.011
    },
    "scope": "global_adult_lifetime"
  },
  "sources": [
    {
      "url": "https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025",
      "title": "Global Tuberculosis Report 2025 — Factsheet",
      "publisher": "World Health Organization",
      "source_type": "govt_report",
      "statistic": "TB caused an estimated 1.23 million deaths in 2024 (including 150,000 people with HIV); 10.7 million people fell ill with TB; 8.3 million were newly diagnosed and reported — a record high, up from 8.2 million in 2023 and 78% of estimated incident cases. 390,000 people developed RR-TB and only 164,545 (42%, ~2 in 5) were treated. TB is the world's leading cause of death from a single infectious agent.",
      "excerpt": "\"Globally in 2024, TB caused an estimated 1.23 million deaths, including 150 000 people with HIV. … In 2024, an estimated 10.7 million people fell ill with TB worldwide, including 5.8 million men, 3.7 million women and 1.2 million children. … Globally in 2024, 8.3 million people were reported as newly diagnosed with TB in 2024 — a small increase from 8.2 million in 2023 and 78% of the estimated number of incident cases. … A total of 164 545 people were treated for rifampicin-resistant TB (RR-TB) in 2024. This was 42% of the approximately 390 000 people who developed RR-TB in 2024. … Tuberculosis (TB) is the world's leading cause of death from a single infectious agent and among the top 10 causes of death worldwide.\"\n",
      "source_date": "2025-11-14",
      "source_accessed": "2026-06-14",
      "archive_url": "http://web.archive.org/web/20260611091910/https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025",
      "calculation_notes": "WHO Global TB Report 2025 reports ~1.23 million annual TB deaths for reference year 2024, a small decline from the ~1.25 million reported for 2023. Divided by ~8 billion global population gives an annual per-capita hazard of ~1.54 × 10⁻⁴; compounded over 60 adult years yields 1 − (1 − 1.54e-4)^60 ≈ 9.2 × 10⁻³, i.e. roughly 1 in 109 — within the prior uncertainty band. The 8.3 million newly diagnosed/reported cases are the highest case count ever recorded (a diagnosis/notification record), while estimated incidence of 10.7 million actually fell ~2% from 2023; the two should not be conflated. MDR/RR-TB treatment access remains ~2 in 5 (42%).\n",
      "independence_note": "WHO Global TB Report is the primary programmatic pipeline; this 2025 edition is the same WHO Global TB Programme source family as the 2024 edition below, used here as the most current reference-year headline.\n"
    },
    {
      "url": "https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024/tb-disease-burden/1-2-tb-mortality",
      "title": "Global Tuberculosis Report 2024 — 1.2 TB mortality",
      "publisher": "World Health Organization",
      "source_type": "govt_report",
      "statistic": "1.09 million TB deaths among HIV-negative people (95% UI 0.98–1.20 million) plus 161,000 deaths among people with HIV (95% UI 132,000–193,000) in 2023; ~1.25 million total. TB deaths from HIV-negative people (1.1 million) were almost double the deaths caused by HIV/AIDS (0.63 million).",
      "excerpt": "\"Globally in 2023, there were an estimated 1.09 million deaths among HIV-negative people (95% uncertainty interval [UI]: 0.98–1.2 million) and an estimated 161 000 deaths among people with HIV (95% UI: 132 000–193 000). … The estimated number of deaths officially classified as caused by TB (i.e. those among HIV-negative people) in 2023, at 1.1 million, was almost double of the number of deaths caused by HIV/AIDS (0.63 million). … Now that COVID-19 has receded as a global public health emergency, in 2023 TB probably returned to being the leading cause of death from a single infectious agent.\"\n",
      "source_date": "2024-10-29",
      "source_accessed": "2026-04-11",
      "archive_url": "http://web.archive.org/web/20260217220014/https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024/tb-disease-burden/1-2-tb-mortality",
      "calculation_notes": "1.09M HIV-negative + 161K HIV-positive = ~1.25M total annual TB deaths globally for reference year 2023. Divided by ~8 billion global population gives an annual per-capita hazard of 1.56 × 10⁻⁴; compounded over 60 adult years yields 1 − (1 − 1.56e-4)^60 ≈ 9.3 × 10⁻³, i.e. roughly 1 in 108. The ~95% uncertainty interval on HIV-negative TB deaths alone (0.98–1.20 million) plus the HIV-positive contribution drives the uncertainty band used in the normalized figure.\n",
      "independence_note": "WHO Global TB Report is the primary programmatic pipeline — country-reported case/death notifications aggregated and modelled by the WHO Global TB Programme. Methodologically distinct from IHME's GBD Cause of Death Ensemble model (cited below), which uses overlapping upstream vital registration data but independent modelling; the two anchors genuinely triangulate the global figure.\n"
    },
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/38518787/",
      "title": "Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021",
      "publisher": "Lancet Infectious Diseases / GBD 2021 Tuberculosis Collaborators",
      "source_type": "peer_reviewed",
      "statistic": "GBD 2021 estimated 9.40 million (95% UI 8.36–10.5) TB incident cases and 1.35 million (1.23–1.52) TB deaths in 2021. Global TB mortality fell ~12% between 2015 and 2020 — short of the WHO End TB Strategy 35% target. Mortality decline was 35.3% in children under 5 but only 3.3% in adults 70+.",
      "excerpt": "\"The GBD 2021 study estimated 9.40 million (95% uncertainty interval [UI] 8.36 to 10.5) tuberculosis incident cases and 1.35 million (1.23 to 1.52) deaths due to tuberculosis in 2021. … Globally, between 2015 and 2020, the all-age tuberculosis incidence rate declined by 6.3% and tuberculosis mortality declined by 12%, both falling short of the WHO End TB Strategy 2020 milestones of 20% and 35% reductions, respectively.\"\n",
      "source_date": "2024-07-01",
      "source_accessed": "2026-04-11",
      "archive_url": "http://web.archive.org/web/20260116043106/https://pubmed.ncbi.nlm.nih.gov/38518787/",
      "calculation_notes": "GBD 2021 is an independent modeling exercise from IHME and is the peer-reviewed corroboration of the WHO programmatic figure. GBD estimates ~1.35M TB deaths in 2021 vs WHO’s ~1.4M; the two systems agree on order of magnitude and on the conclusion that TB remains the leading infectious cause of death globally. The spread between the two headline estimates (~1.25M WHO 2023 vs ~1.35M GBD 2021) is the main driver of the upper end of the uncertainty band.\n",
      "independence_note": "GBD is an IHME-led modeling exercise that uses its own cause-of-death pipeline and vital registration ensemble model, independent of WHO’s programmatic TB estimates. The two have known methodological differences (GBD typically reports slightly higher TB mortality than WHO) and are treated here as two genuinely independent anchors.\n"
    },
    {
      "url": "https://www.cdc.gov/tb-surveillance-report-2024/data/deaths.html",
      "title": "Deaths Among Persons with TB: 2010–2022 (Reported Tuberculosis in the United States, 2024)",
      "publisher": "US Centers for Disease Control and Prevention (CDC)",
      "source_type": "govt_report",
      "statistic": "858 deaths among US persons with TB in 2022 (most recent year with death data); of these, 349 (41%) were related to TB disease or TB therapy. Annual totals 2010–2022 range from 769 to 944.",
      "excerpt": "\"In 2022, the most recent year for which death data are available, 858 deaths were reported by TB programs. … Of 858 deaths, 349 (41%) were related to TB disease or TB therapy. … Among 2022 deaths, 246 (29%) were among persons who were dead at diagnosis and 612 (71%) were among persons who died after diagnosis.\"\n",
      "source_date": "2024-10-24",
      "source_accessed": "2026-04-11",
      "archive_url": "http://web.archive.org/web/20260318025943/https://www.cdc.gov/tb-surveillance-report-2024/data/deaths.html",
      "calculation_notes": "CDC reports ~858 deaths per year among US persons with TB in 2022 but classifies only ~349 (41%) as actually caused by TB disease or therapy. Against a US population of ~335 million, the TB-attributed figure is ~1.0 × 10⁻⁶ per year — roughly 1 in a million per year, or ~6 × 10⁻⁵ (1 in ~16,000) compounded over 60 adult years. That is approximately 150 times lower than the global average and is the basis for the “US / Western Europe / Japan” row in the regional breakdown.\n",
      "independence_note": "CDC US TB surveillance is a completely separate data pipeline from both WHO programmatic estimates and IHME’s GBD model. It is used here solely as the non-endemic anchor and is not in the triangulation of the global figure.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Death from a mosquito-borne disease (lifetime, global adult)",
      "lifetime_us_adult": 0.00525
    },
    {
      "label": "Death from food poisoning (lifetime, global adult)",
      "lifetime_us_adult": 0.00315
    },
    {
      "label": "Death in a car crash (lifetime, US)",
      "lifetime_us_adult": 0.0108
    },
    {
      "label": "Death in a plane crash (lifetime, US adult)",
      "lifetime_us_adult": 0.000017
    }
  ],
  "regional_breakdown": [
    {
      "region": "Global average",
      "probability": 0.0093,
      "notes": "~1.25M TB deaths/yr across 8B people, compounded over 60 adult years. A scale marker, not a personal estimate."
    },
    {
      "region": "India / Indonesia / Philippines",
      "probability": 0.04,
      "notes": "India alone accounts for roughly a quarter of global TB deaths; South and Southeast Asia together dominate the global incidence."
    },
    {
      "region": "Sub-Saharan Africa (high HIV prevalence)",
      "probability": 0.05,
      "notes": "HIV-TB co-infection drives case-fatality up from ~15% to closer to 40–50%; TB is the leading cause of death among people living with HIV."
    },
    {
      "region": "US / Western Europe / Japan",
      "probability": 0.00005,
      "notes": "Essentially absent as a population risk. CDC reports ~350 TB-attributed deaths per year in the US (~1 in a million annually)."
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "HIV positive (untreated)",
      "multiplier": 30,
      "notes": "WHO: people living with HIV are roughly 12x more likely to develop active TB; case-fatality is also dramatically higher without ART."
    },
    {
      "factor": "Household contact with active TB",
      "multiplier": 25,
      "notes": "Close household contacts of an infectious case carry substantially elevated risk of both infection and progression to disease."
    },
    {
      "factor": "Malnourished or immunocompromised",
      "multiplier": 4,
      "notes": "Undernutrition is one of the largest attributable risk factors for TB incidence in GBD 2021."
    },
    {
      "factor": "Resident of Bangladesh / Pakistan / India",
      "multiplier": 30,
      "notes": "South Asia carries a disproportionate share of global TB mortality; per-capita risk is an order of magnitude or more above the global average."
    }
  ],
  "short_label": "Tuberculosis (global)",
  "myth_framing": "underrated",
  "outcome_severity": "fatal",
  "exposure_pattern": "cumulative",
  "outcome_type": "death",
  "valence": "negative",
  "caveats": "The ~1 in 110 figure is a global-average scale marker and is almost useless as a personal estimate. Tuberculosis mortality is overwhelmingly concentrated in eight countries (India, Indonesia, China, Philippines, Pakistan, Nigeria, Bangladesh, and South Africa) which together account for roughly two thirds of global cases, and within those countries risk is further concentrated in people living with HIV, in malnourished populations, in prisons and crowded institutional settings, and in household contacts of active cases. For residents of the US, Western Europe, Japan, and Australia without any of those risk factors, annual risk is ~1 in a million or lower — a gap of roughly five orders of magnitude versus the global headline. The global number has also been moving: TB deaths rose during 2020–2022 as COVID-19 disrupted TB programs, then began declining again. The WHO Global TB Report 2025 (reference year 2024) put deaths at ~1.23 million and ill people at 10.7 million — both modest declines from 2023 — while a record 8.3 million people were newly diagnosed and reported, the highest case count ever recorded (a detection/notification record, not a sign the epidemic grew). Drug-resistant TB remains a persistent gap: of the ~390,000 people who developed rifampicin-resistant TB in 2024, only about 42% — roughly 2 in 5 — accessed treatment (WHO Global TB Report 2025).\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 5,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.875,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "likelier-phase-5-agent",
  "last_reviewed": "2026-06-14",
  "reviewed": true,
  "generated_at": "2026-04-11",
  "image": {
    "alt": "A single muted lung-shaped leaf on a pale neutral background, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/tuberculosis-global"
}